FLAVNT Streetwear, LLC
Letter data
- Company
- FLAVNT Streetwear, LLC
- Recipient
- Christopher Rhodes | Manager | FLAVNT Streetwear, LLC | 6303 Virgo Ln | Austin | , | TX | 78724-4322 | United States | abuse@flavnt.com
- Issue date
- 2026-03-27
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 720838
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
FLAVNT Streetwear, LLC
MARCS-CMS 720838 —
March 27, 2026
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Medical Devices
Recipient:
Recipient Name
Christopher Rhodes
Recipient Title
Manager
FLAVNT Streetwear, LLC
6303 Virgo Ln
Austin
,
TX
78724-4322
United States
abuse@flavnt.com
Issuing Office:
Center for Devices and Radiological Health
United States
Secondary Issuing Offices
United States
Dear Christopher Rhodes:
The Food and Drug Administration (FDA) has completed an evaluation of FLAVNT Streetwear, LLC corrective actions in response to our Warning Letter CMS #720838, dated December 16th, 2025. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Michael J. Hoffmann
Office Director
OHT3: Office of GastroRenal, ObGyn,
General Hospital and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Christopher Rhodes
FLAVNT Streetwear, LLC
cc: Shopify, Inc. abuse@shopify.com
cc: yourpals@flavnt.com
Content current as of:
03/31/2026
Regulated Product(s)
Medical Devices